or
activation, influencing the expression of oncogenes and tumor suppressor genes. Such alterations have
Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) by inducing tissue fractionation through bubble
activity, offering advantages such as tissue selectivity
strategies that go beyond managing symptoms to
actively promote brain repair and functional recovery. Current
Larionova, Irina,
Iamshchikov, Pavel,
Kazakova, Anna,
Rakina, Militsa,
Menyalo, Maxim,
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Pavlov, Valentin,
Villert, Alisa,
Kolomiets, Larisa,
Kzhyshkowska, Julia (2025) that chemotherapy inhibited interferon-dependent signaling pathways, but
activated some TGFb-related genes. Our